Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal red blood cell transfusions.

Naomi L C Luban1

  • 1Department of Pediatrics, George Washington University School of Medicine, Washington, DC, USA. nluban@cnmc.org

Current Opinion in Hematology
|October 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red Blood Cell Transfusion Characteristics and Morbidity or Mortality in Very-Low-Birth-Weight Infants.

JAMA network open·2026
Same author

Epidemiology of Pediatric Transfusion Reactions.

JAMA network open·2026
Same author

Neonatal outcomes following maternal red cell transfusions prior to or at delivery.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

International classification of diseases codes have low positive predictive value for neonatal morbidities.

Journal of perinatology : official journal of the California Perinatal Association·2025
Same author

Temporal Trends in Red Blood Cell and Platelet Transfusion Thresholds for Extremely Low Birth Weight Infants.

The Journal of pediatrics·2025
Same author

Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden.

Transfusion·2024
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Transfusions in premature infants require clear indications beyond hemoglobin levels, considering clinical signs and comorbidities. New methods are needed to assess oxygen delivery and utilization in these vulnerable neonates.

Area of Science:

  • Neonatal medicine
  • Transfusion medicine
  • Pediatric hematology

Background:

  • Red blood cell transfusions in neonates often lack defined indications, leading to adverse outcomes.
  • Current practices for premature infants involve small-volume transfusions using specific blood products to minimize donor exposure.
  • Existing safety protocols for these transfusions are established, but indications require further clarification.

Purpose of the Study:

  • To evaluate the current indications for red blood cell transfusions in premature infants.
  • To highlight the limitations of using hemoglobin or hematocrit alone for transfusion decisions.
  • To emphasize the need for improved methods to assess oxygen delivery and utilization in neonates.

Main Methods:

  • Review of current transfusion practices for premature infants.

Related Experiment Videos

  • Analysis of clinical findings and comorbidities influencing oxygen demand.
  • Identification of the need for novel noninvasive methods or assays.

    • Main Results:

    • Hemoglobin or hematocrit levels alone are insufficient criteria for transfusion in premature infants.
    • Clinical findings (e.g., oxygen desaturation, apnea, bradycardia) and comorbidities (e.g., bronchopulmonary dysplasia) must inform transfusion decisions.
    • Current methods do not adequately reflect the unique pathophysiology of oxygen delivery and offloading in neonates.

    Conclusions:

    • Transfusion guidelines for premature infants need refinement, incorporating clinical status and comorbidities.
    • Development of noninvasive methods is crucial for accurately assessing transfusion needs in neonates.
    • Optimizing transfusion practices is essential to improve outcomes for premature infants.